Business Context and Reporting Period
This Form 6-K filing by Check-Cap Ltd. (referred to as Mbody AI Ltd. in metadata) covers the period ending September 27, 2017. The company is a foreign private issuer based in Israel, focusing on medical technology. The filing primarily serves to disclose a significant regulatory milestone regarding its C-Scan® product.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity figures. This report is a current event disclosure rather than a financial statement.
Material Changes
The material change reported is the initiation of the regulatory approval process for the company's core product:
- On September 27, 2017, Check-Cap Ltd. filed for CE Mark registration for its C-Scan® device.
- The company hosted a management conference call to discuss this development, featuring the CEO, Principal Investigator, and COO.
Guidance, Outlook, and Risks
Management commentary was delivered via a conference call and a presentation (Exhibit 99.2) attached to the filing, focusing on the CE Mark filing. The text does not contain specific forward-looking financial guidance, quantitative risk factors, or details on contingencies beyond the regulatory filing itself.
Investor Verification Checklist
- Verify the status and timeline of the CE Mark registration for C-Scan® following the September 2017 filing.
- Review the attached press release (Exhibit 99.1) and presentation (Exhibit 99.2) for specific technical details and management expectations.
- Confirm the company's current cash runway and funding status, as this filing does not disclose liquidity metrics.
- Monitor subsequent filings for updates on the regulatory approval outcome.